Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Surong Hua

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3630-3954; OpenAlex author ID A5055143613. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 4

  1. An iron-containing nanomedicine for inducing deep tumor penetration and synergistic ferroptosis in enhanced pancreatic cancer therapy. Co-author DOI 10.1016/j.mtbio.2024.101132↗
  2. Pathological complete response in a patient with locally advanced pancreatic adenocarcinoma treated with neoadjuvant gemcitabine and S-1: a case report and lit… Co-author DOI 10.21037/gs-22-6↗
  3. The promoting effects of hsa_circ_0050102 in pancreatic cancer and the molecular mechanism by targeting miR-1182/NPSR1. Co-author DOI 10.1093/carcin/bgaa130↗
  4. Comprehensive Analysis of Expression, Prognostic Value, and Immune Infiltration for Ubiquitination-Related FBXOs in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fimmu.2021.774435↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Junyi Gao · 4 shared papers, 2021–2024 · strength 0.72
  2. Quan Liao · 2 shared papers, 2021 · strength 0.29
  3. Mengyi Wang · 2 shared papers, 2021 · strength 0.29
  4. Wenhu Zhou · 1 shared paper, 2024 · strength 0.23
  5. Aiping Huang · 1 shared paper, 2024 · strength 0.23
  6. Wenming Wu · 1 shared paper, 2022 · strength 0.20
  7. Yalu Zhang · 1 shared paper, 2021 · strength 0.15
  8. Qiaofei Liu · 1 shared paper, 2021 · strength 0.15
  9. Ming Cui · 1 shared paper, 2021 · strength 0.15
  10. Tong Li · 1 shared paper, 2021 · strength 0.14
  11. Xianlin Han · 1 shared paper, 2021 · strength 0.14
  12. Lei You · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.